UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Annals of oncology, 2018-10, Vol.29, p.viii63-viii63

2018

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Annals of oncology, 2018-10, Vol.29, p.viii58-viii59

2018

Volltextzugriff (PDF)

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi31

2017

Volltextzugriff (PDF)

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi27

2017

Volltextzugriff (PDF)

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis

European journal of cancer (1990), 2011, Vol.47, p.S587-S587

2011

Volltextzugriff (PDF)

239MO TILs and overall survival (OS) in HER2+ early breast cancer (eBC): 10-year (yr) updated analysis of the ShortHER trial

Annals of oncology, 2024-09, Vol.35, p.S313-S313

2024

Volltextzugriff (PDF)

Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series

European journal of cancer (1990), 2024-03, Vol.200, p.113619, Article 113619

2024

Volltextzugriff (PDF)

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-04

2019

Volltextzugriff (PDF)

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Annals of oncology, 2020-05, Vol.31, p.S23-S23

2020

Volltextzugriff (PDF)

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

Annals of oncology, 2017-09, Vol.28, p.v63-v63

2017

Volltextzugriff (PDF)

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

Annals of oncology, 2012-09, Vol.23, p.ix124

2012

Volltextzugriff (PDF)

186OTumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-20

2017

Volltextzugriff (PDF)

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-06

2017

Volltextzugriff (PDF)

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi53-vi53

2016

Volltextzugriff (PDF)

Abstract P1-13-02: Withdrawn

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-13-02

2018

Volltextzugriff (PDF)

Analysis of HER1 and HER2 status in CNS metastases from patients (pts) with breast carcinoma (BC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1041-1041

2008

Volltextzugriff (PDF)

Triple negative breast cancer: Adjuvant treatment and outcome of 62 patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e11636-e11636

2009

Volltextzugriff (PDF)

Un poemetto inedito di Bernardino Giambullari

Bibliothèque d'humanisme et renaissance, 1977-09, Vol.39 (3), p.531

Orvieto, E

1977

Volltextzugriff (PDF)

Differential diagnosis of metastatic adenocarcinoma to the liver: Utility of the nuclear trancription factor CDX2

Journal of hepatology, 2003-04, Vol.38, p.94-95

2003

Volltextzugriff (PDF)

LA BURLA DI LORENZO DE' MEDICI A FRA MARIANO

Bibliothèque d'humanisme et renaissance, 1981-09, Vol.43 (3), p.537-544

Orvieto, Enzo

1981

Volltextzugriff (PDF)

Due sonetti inediti di A. Tassoni

Forum italicum, 1969-12, Vol.3 (4), p.585

Orvieto, E

1969

Volltextzugriff (PDF)

SAN FRANCESCO E IL DIAVOLO CONTRASTO INEDITO CINQUECENTESCO IN TERZA RIMA

Forum italicum, 1973-12, Vol.7 (4), p.3-21

Orvieto, Enzo

1973

Volltextzugriff (PDF)

Breast cancer at the end of a successful century: Meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14–16 June, 2000)

Breast (Edinburgh), 2000-06, Vol.9 (3), p.161-170

2000

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis

239MO TILs and overall survival (OS) in HER2+ early breast cancer (eBC): 10-year (yr) updated analysis of the ShortHER trial

Heterogeneity of ER, PgR, HER2 and Ki67 in multifocal/multicentric breast cancer with a single histotype and same grade: implications for pathologists and oncologists from a large multi-institutional series

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

186OTumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Abstract P1-13-02: Withdrawn

Analysis of HER1 and HER2 status in CNS metastases from patients (pts) with breast carcinoma (BC)

Triple negative breast cancer: Adjuvant treatment and outcome of 62 patients

Un poemetto inedito di Bernardino Giambullari

Differential diagnosis of metastatic adenocarcinoma to the liver: Utility of the nuclear trancription factor CDX2

LA BURLA DI LORENZO DE' MEDICI A FRA MARIANO

Due sonetti inediti di A. Tassoni

SAN FRANCESCO E IL DIAVOLO CONTRASTO INEDITO CINQUECENTESCO IN TERZA RIMA

Breast cancer at the end of a successful century: Meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14–16 June, 2000)

Aktive Filter

Suchergebnisse filtern